PIRAMAL PHARMA
Back to Balance Sheet
|
PIRAMAL PHARMA Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹96 Cr | ₹100 Cr | ₹61 Cr | ₹57 Cr | ₹45 Cr |
What is the latest Contingent Liabilities ratio of PIRAMAL PHARMA ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹96 Cr |
| Mar2025 | ₹100 Cr |
| Mar2024 | ₹61 Cr |
| Mar2023 | ₹57 Cr |
| Mar2022 | ₹45 Cr |
How is Contingent Liabilities of PIRAMAL PHARMA Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹96 Cr | -4.05 | |
| Mar2025 | ₹100 Cr | 62.40 | |
| Mar2024 | ₹61 Cr | 7.17 | |
| Mar2023 | ₹57 Cr | 27.55 | |
| Mar2022 | ₹45 Cr | - | |
Compare Contingent Liabilities of peers of PIRAMAL PHARMA
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| PIRAMAL PHARMA | ₹28,509.8 Cr | 3.7% | 23.2% | 9.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹465,471.0 Cr | -0.5% | 0.8% | 19% | Stock Analytics | |
| DIVIS LABORATORIES | ₹226,631.0 Cr | 2.2% | 23.1% | 27.4% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹185,157.0 Cr | -2.6% | -1.6% | 36% | Stock Analytics | |
| CIPLA | ₹118,108.0 Cr | 0.8% | 2.5% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,578.0 Cr | 2.6% | -2.4% | -5.6% | Stock Analytics | |
PIRAMAL PHARMA Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| PIRAMAL PHARMA | 3.7% |
23.2% |
9.5% |
| SENSEX | -0.4% |
0.8% |
-3% |
You may also like the below Video Courses